We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

Eli Lilly's dual GLP-1/GIP agonist tirzepatide ... which is already sold as Mounjaro for type 2 diabetes and Zepbound for obesity, later this year. The SUMMIT trial enrolled obese patients with ...

Jim Cramer says the Fed action is great news for high-growth tech stocks, which should be among the first sectors to recover.